Innovative clinical trials focusing on lung cancer treatments, including studies of combination therapies with BNT327 and investigations into both small cell and non-small cell variants. Additional research covers breast cancer and cervical cancer treatments.

Non-small cell lung cancer therapy optimization
Advanced solid tumors treatment
Lymphoma treatment innovations

Studies aim to improve survival rates and treatment effectiveness through targeted therapies and immunotherapy combinations.

02 Cardiovascular Studies

Comprehensive research into coronary artery disease and post-stroke treatments, evaluating new antiplatelet therapies and innovative stent technologies. Studies focus on reducing cardiovascular events and improving patient outcomes.

Acute coronary syndrome management
Stroke prevention strategies
Antiplatelet therapy optimization

Investigations aim to enhance treatment protocols and reduce cardiovascular complications.

03 Autoimmune Conditions

Groundbreaking research in multiple sclerosis and psoriatic arthritis treatments, evaluating novel therapeutic approaches including BTK inhibitors and biological treatments.

Progressive MS treatment development
Arthritis management innovations
Long-term therapy effectiveness

Focus on improving quality of life and disease management for patients with chronic autoimmune conditions.

Back to Belgium All countries

Clinical trials in Mons – page 3

48 trials in Mons

Axial spondyloarthritis

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Acute coronary syndrome

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Small cell lung cancer extensive stage

Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

Primary progressive multiple sclerosis

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Study Comparing Savolitinib and Osimertinib with Chemotherapy for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation and MET Overexpression

Study Comparing Savolitinib and Osimertinib with Chemotherapy for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation and MET Overexpression

Hormone receptor positive HER2 negative breast cancer

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Rectal cancer stage III+1

Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

Breast cancer female

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Non-small cell lung cancer metastatic

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Neoplasm

Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

Hypertension

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Hypertension

Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

Filter the trials

Other cities in Belgium

Clinical research in Mons

Prefer not to search? Our Concierge searches the trials for you.